Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results60% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 1 (2)
P 4 (2)

Trial Status

Unknown4
Completed3
Terminated2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (11)

Research Network

Activity Timeline